Key result
Mechanical thrombus aspiration safely removes device-related thrombus after LAAC in all 7 patients.
Why the study?
Despite technological advances, device-related thrombus after left atrial appendage closure remains a concern, prompting evaluation of a novel mechanical thrombus aspiration system.
Does mechanical thrombus aspiration safely and effectively remove device-related thrombus after left atrial appendage closure?
Observational (n=7)
Does mechanical thrombus aspiration safely and effectively remove device-related thrombus after left atrial appendage closure?
Mechanical thrombus aspiration with cerebral embolic protection appears to be a safe and effective bailout strategy for device-related thrombus after left atrial appendage closure.
Answers are grounded in this paper and cite their sources.
No residual LAAC thrombus on aspirin in small series; hypothesis-generating for antithrombotic regimens, needs prospective validation.
Background Despite technological advances, device related thrombus (DRT) after left atrial appendage closure (LAAC) remains a concern. Purpose To assess safety and efficacy of a novel mechanical thrombus aspiration (MTA) system Methods 7(mean age 76±11years, 4 males) consecutive patients underwent MTA with Flowrunner 14Fr-100cm catheter, guided by both transesophageal (TEE) and intracardiac echocardiography, were included in this analysis. All patients underwent thromboembolic protection using a modified Watchman device deployed in the ascending aorta. The appropriate device size was chosen according to the corresponding diameter of the ascending aorta. The system consisted of a dual-catheter design with a distal valve, where the inner catheter rapidly advanced and retracted to aspirate and fragment the thrombus, while the valve prevented blood ingress and minimized blood loss through saline flushing. Results Mean CHADS2VA was 5±1. Mean time from LAAC implantation was 16±8months. 6 patients had a WatchmanFLX and 1 patient an Amulet. All patients were receiving aspirin at the time the clot was detected. Mean clot size was 13±4 x 19±6 mm. Total aspiration time was 9±3 minutes. Blood loss was 70±15 cc. No residual thrombus was seen on the LAAC device at the end of the procedure. When removing the modified watchman from the aorta no clot was found on the device. No patients experienced neurological symptoms after the procedure, and all were discharged on a half-dose oral anticoagulation regimen. At the TEE follow-up after 63±16 days no DRT was found on the device. Conclusion MTA was safe, effective, and achieved complete thrombus removal.
No takes yet. Share an insight, caveat, or question.
Fazia et al. (2026) conducted an observational in Device related thrombus after left atrial appendage closure (n=7). Mechanical thrombus aspiration was evaluated on Safety and efficacy (thrombus removal and neurological symptoms). Mechanical thrombus aspiration for device-related thrombus after LAAC achieved complete thrombus removal in all 7 patients with no neurological complications.
Synapse has enriched 10 related papers. Consider them for comparative context: